Patterns of diagnosis for colorectal cancer: Screening detected vs. symptomatic presentation

Diseases of the Colon and Rectum

Volumn 51, Issue 5, 2008, Pages 573-577

  Smiljanic, Sasha ^a,b   Gill, Sharlene ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b LIONS GATE HOSPITAL   (Canada)

Author keywords

Cancer; Colorectal; Compliance; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER CENTER; CANCER DIAGNOSIS; CANCER INVASION; CANCER MORPHOLOGY; CANCER PATIENT; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; COMPARATIVE STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCREENING TEST; SYMPTOMATOLOGY;

AGED; BRITISH COLUMBIA; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DEMOGRAPHY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 43049150033     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-008-9193-8     Document Type: Article

References (21)

1. Colorectal cancer screening. Recommendation statement from the Canadian task force on preventive health care. Can Fam Physician 2001;47:1811-5.
2. Canada, N.C.I.o. Progress in cancer control: screening. Available at: http://www.ncic.cancer.ca/ncic/internet/standard/0,3621, 84658243_85787780_91036035_langId-en,00.html. Accessed April 14, 2006.
3. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284:1954-61.
4. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 2000;95:868-77.
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
6. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
7. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
8. Mandel JS, Bond JH, Church TR, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
9. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
10. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
11. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
12. Winawer SJ, Zauber AG, Ho MN. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
13. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-13.
14. Centers for Disease Control and Prevention. Trends in screening for colorectal cancer: United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep 2001;50:162-6.
15. Erban S, Zapka J, Puleo E, Vickers-Lahti M. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines. Eff Clin Pract 2001;4:10-7.
16. BCMA. Guidelines and protocols: detection of colorectal neoplasms in asymptomatic patients. March 1, 2004. Available at: http://www.health.gov.bc.ca/ msp/protoguides/gps/colorectal_det.pdf. Accessed March 7, 2006.
17. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health 1995;85:840-2.
18. Burack RC, Liang J. The early detection of cancer in the primary-care setting: factors associated with the acceptance and completion of recommended procedures. Prev Med 1987;16:739-51.
19. Gordon NP, Rundall TG, Parker L. Type of health care coverage and the likelihood of being screened for cancer. Med Care 1998;36:636-45.
20. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89:1406-22.
21. Church TR, Yeazel MW, Jones RM. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst 2004;96:770-80.